Table 5.

Changes in immunohistochemical scoring according to histopathological and clinical characteristics of endometrial cancer patients.

Protein	Tumor/control		Tumor differentiation (high grade vs. low grade)	Menopausal status	FIGO stage (IA vs. IB-IV)	Myometrial invasion (yes/no)	Lympho-vascular invasion (yes/no)	Vital status
	Fold-change	p	p	p	p	p	p	p
STS	0.73	0.0219	0.6383	0.8962	0.8787	0.5752	0.693	0.7503
HSD17B2	1.45	0.0236	0.5055	0.5419	0.9576	0.45	0.7844	0.4178
SULT1E1	0.59	0.0678	0.657	0.0535	0.8447	0.6497	0.1287	0.3016

The differences in expression levels in tumor as compared to the adjacent control endometrium were analyzed using Wilcoxon matched-pair tests. Stratification analysis were done using 2-way ANOVA. The differences in p-values of < 0.05 were considered significant and are marked in bold.